Antipsychotic metabolic monitoring — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Weight, glucose or HbA1c, lipids and blood pressure
Olanzapine can cause weight gain and metabolic adverse effects. Baseline and ongoing monitoring should include weight, glycaemic status, lipids and blood pressure. Early lifestyle advice and prescriber review are important if weight gain emerges. The other monitoring sets do not match the main risks of olanzapine.
Reference: BNF; NICE CKS